VERMOX 2% price in UAE

Overview

Welcome to Dwaey, specifically on VERMOX 2% Suspension page.
This medicine contains an important and useful components, as it consists of Mebendazole.
VERMOX 2% is available in the market in concentration 20mg/ml and in the form of Suspension.

JANSSEN PHARMACEUTICA N.V. is the producer of VERMOX 2% and it is imported from BELGIUM, The most popular alternatives of VERMOX 2% are listed downward .

Mode Of Action

Mebendazole inhibits formation of helminth microtubules. It selectively and irreversibly blocks the uptake of glucose and other nutrients in susceptible helminths, resulting in endogenous depletion of glycogen stores in the helminth.

Indication

Enterobiasis
Hookworm infections
Filariasis
Toxocariasis
Ascarisis
Trichuriasis
Trichostrongyliasis
Trichinellosis
Dracunculiasis

Precaution

Hepatic impairment. Childn. Pregnancy and lactation. Monitoring Parameters Periodic assessment of haematologic, hepatic, and renal function; check for helminth ova in faeces w/in 3-4 wk following the initial therapy. Lactation: Excretion in breast milk unknown; use caution

Side Effects

Transient diarrhoea
abdominal pain
nausea
vomiting
headache
tinnitus
numbness
fever
alopecia
rash
pruritus
urticaria
angioedema
flushing
hiccups
cough
weakness
drowsiness
chills
hypotension
seizures
transient abnormalities in LFT (e.g. increased serum concentrations of aminotransferases
glutamyltransferase alkaline phosphatase
and/or bilirubin)
hepatitis
increased BUN
decreased Hb concentration and/or hematocrit
leucopenia
eosinophilia
haematuria
cylindruria
migration of roundworms through the mouth and nose. Potentially Fatal: Myelosuppression
manifested as neutropenia (including agranulocytosis) and/or thrombocytopenia.

Contra indication

Hypersensitivity. Infants and children <2 yr.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks